Adverse events during treatment · adults and children with cystic fibrosis
The review found no eligible studies for this question.
2 findings from 1 review
Quality of life · adults and children with cystic fibrosis
1 finding from 1 review
Change in sputum P aeruginosa density at end of treatment (cfu/g) · adults and children with cystic fibrosis
Summary of findings: single showed no clear difference in change in sputum P aeruginosa density at end of treatment (cfu/g) compared with combination intravenous anti‐pseudomonal antibiotic therapy (moderate certainty).
2 findings from 1 review
Need for extra treatment · adults and children with cystic fibrosis
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Quality of life  · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FEV1 % predicted: absolute change from baseline · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FEV1 % predicted · children with cystic fibrosis
1 finding from 1 review
Number of people with one or more isolates of S aureus (sensitive strains) · children with cystic fibrosis
Summary of findings ‐ Prophylactic may leads to lower number of people with one or more isolates of S aureus (sensitive… compared with 'as required' anti‐staphylococcal antibiotics (low certainty).
1 finding from 1 review
Number of people with one or more isolates of P aeruginosa · children with cystic fibrosis
Summary of findings ‐ Prophylactic showed no clear difference in number of people with one or more isolates of P aeruginosa compared with 'as required' anti‐staphylococcal antibiotics (low certainty).
1 finding from 1 review
Weight (z score) · children with cystic fibrosis
1 finding from 1 review
Acquisition of multiply‐resistant S aureus · children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events of treatment · children with cystic fibrosis
1 finding from 1 review
Number of participants with a complication attributed to the index infection · patients with sore throat
1 finding from 1 review
Number of participants in need of re‐consultation by the end of · patients with sore throat
1 finding from 1 review
Surgical site infections: liver transplant recipients Time frame: 30 days · solid organ transplant recipients
It is very uncertain whether extended changes surgical site infections: liver transplant recipients Time frame: 30… compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Death (any case) Time frame: 2 to 4 weeks · solid organ transplant recipients
It is very uncertain whether extended changes death (any cause) Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Graft loss including death · solid organ transplant recipients
It is very uncertain whether extended changes graft loss (including death with functioning graft) Time frame: 30… compared with short duration antibiotics (very low certainty).
1 finding from 1 review
UTI · solid organ transplant recipients
It is very uncertain whether extended changes other infection: UTI Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Other infection: septicaemia Time frame: 2 to 6 weeks · solid organ transplant recipients
It is very uncertain whether extended changes other infection: septicaemia Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review
Other infection: pneumonia Time frame: 30 days · solid organ transplant recipients
It is very uncertain whether extended changes other infection: pneumonia Time frame: 30 days compared with short duration antibiotics (very low certainty).
1 finding from 1 review